ArticleJMIR bioinformatics and biotechnology2025
Stacked Deep Learning Ensemble for Multiomics Cancer Type Classification: Development and Validation Study.
Article in JMIR bioinformatics and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence-driven advancements in agricultural biotechnology.Journal, genetic engineering & biotechnology · 2026Review
- Computational models for pan-cancer classification based on multi-omics data.Frontiers in genetics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cancer is one of the leading causes of disease burden globally, and early and accurate diagnosis is crucial for effective treatment. This study presents a deep learning-based model designed to classify 5 common types of cancer in Saudi Arabia: breast, colorectal, thyroid, non-Hodgkin lymphoma, and corpus uteri. Objective: This study aimed to evaluate whether integrating RNA sequencing, somatic mutation, and DNA methylation profiles within a stacking deep learning ensemble improves cancer type classification accuracy relative to the current state-of-the-art multiomics models. Methods: Using a stacking ensemble learning approach, our model integrates 5 well-established methods: support vector machine, k-nearest neighbors, artificial neural network, convolutional neural network, and random forest. The methodology involves 2 main stages: data preprocessing (including normalization and feature extraction) and ensemble stacking classification. We prepared the data before applying the stacking model. Results: The stacking ensemble model achieved 98% accuracy with multiomics versus 96% using RNA sequencing and methylation individually, 81% using somatic mutation data, suggesting that multiomics data can be used for diagnosis in primary care settings. The models used in ensemble learning are among the most widely used in cancer classification research. Their prevalent use in previous studies underscores their effectiveness and flexibility, enhancing the performance of multiomics data integration. Conclusions: This study highlights the importance of advanced machine learning techniques in improving cancer detection and prognosis, contributing valuable insights by applying ensemble learning to integrate multiomics data for more effective cancer classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.